Keyword: Fred Hutchinson Cancer Research Center
HIV mutates to evade immune antibodies that defend against pathogens. A Fred Hutch team has gained new insights into those mutations.
A Fred Hutch team has figured out how to kill dormant breast cancer cells using compounds that disrupt a protective signaling system.
The week’s news included antibodies that lower the risks of bone marrow transplants and a new way to target a mutation in epilepsy.
The week’s biotech news included a potential boost to cancer immunotherapy and new insight into a dementia-causing protein.
Recent biotech discoveries include a sensory protein at the heart of hearing and new insights into how CAR-T design affects cancer treatments.
More details on Amazon’s secret skunk-works research division have been revealed, including work in cancer research and EHRs, in reports from CNBC.
The ability to manipulate genes known to play a role in HIV resistance could help eliminate dormant reservoirs of virus that can resurge at any time.
Biotech developments over the past week include promising data from a human trial of male contraception and a new strategy to protect against malaria.
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming with two Seattle-based academic centers.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
